American Clinical Chemistry Analyzer Market by Product (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry Analyzer), by End-User (Academic Research Institutes, Diagnostic Laboratories, Hospitals) - Forecast to 2019
- Report Code: CL 1000
- Publish Date: Feb 2015
The Americas clinical chemistry analyzers market was valued at $1,163.8 million in 2013, and is expected to register a CAGR of 5.2% from 2014 to 2019.
Clinical chemistry is the application of chemical, molecular, and cellular concepts and techniques to understand and evaluate the human health. Routine tests like testing for blood albumin, ALT/SGPT, ammonia, blood gases, and calcium and creatinine levels are required before undergoing advanced tests. Clinical chemistry tests thus form the center stage of the in vitro diagnostics (IVD) market. The major changes in this sector have been brought through the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The clinical chemistry market is expanding, consolidating, and becoming highly competitive with a myriad of opportunities for various new instruments, reagents, calibrators, and other systems. The largest segment of clinical chemistry is the general chemistry testing.
The introduction of user-friendly automated devices has minimized the human efforts and increased the efficiency of diagnostic procedures. For instance, the Ortho Clinical Vitros 350 Chemistry System accommodates up to 40 samples in one of its four trays, allowing laboratories to effectively meet the testing needs of the patient population. These systems, with their enhanced software and elaborate menu, are responsible for the speeding up of the treatment process at lower costs.
The key players of this market are F. Hoffmann La-Roche (Switzerland) Siemens AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (US), Ortho Clinical Diagnostics (US), and Thermo Fisher ScientificInc., (U.S.)
Table of Contents
1 Introduction (Page No. - 10)
1.1 Objectives of the Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology (Page No. - 12)
2.1 Integrated Ecosystem of Clinical Chemistry Analyzers Market
2.2 Arriving at the Clinical Chemistry Analyzer Market Size
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.2.3 Macroindicator-Based Approach
2.3 Assumptions
3 Executive Summary (Page No. - 19)
4 Market Overview (Page No. - 21)
4.1 Introduction
4.2 Clinical Chemistry Analyzers Market: Comparison With Parent Market (Usd Million)
4.3 Market Drivers and Inhibitors
4.4 Opportunities
4.4.1 Growing Opportunities in Emerging Economies
4.5 Trends
4.5.1 Quick Turnaround Time
4.5.2 High Throughput
4.5.3 Demand for Modular Automation
4.6 Key Market Dynamics
5 Americas Clinical Chemistry Analyzers Market, By Type (Page No. - 31)
5.1 Introduction
5.2 Americas Fully Automated Clinical Chemistry Analyzers Market, By Type
6 Americas Clinical Chemistry Analyzers Market, By Technology (Page No. - 38)
6.1 Introduction
7 Americas Clinical Chemistry Analyzer Market, By Geography (Page No. - 43)
7.1 Introduction
7.2 U.S. Clinical Chemistry Analyzers Market
7.2.1 U.S. Clinical Chemistry Analyzers Market, By Type
7.2.2 U.S. Clinical Chemistry Analyzer S Market, By Technology
7.2.3 U.S. Clinical Chemistry Analyzers Market, By End-User
7.3 Canada Clinical Chemistry Analyzers Market
7.3.1 Canada Clinical Chemistry Analyzers Market, By Type
7.3.2 Canada Clinical Chemistry Analyzers Market, By Technology
7.3.3 Canada Clinical Chemistry Analyzers Market, By End-User
7.4 Mexico Clinical Chemistry Analyzers Market
7.4.1 Mexico Clinical Chemistry Analyzers Market, By Type
7.4.2 Mexico Clinical Chemistry Analyzers Market, By Technology
7.4.3 Mexico Clinical Chemistry Analyzers Market, By End-User
7.5 Chile Clinical Chemistry Analyzers Market
7.5.1 Chile Clinical Chemistry Analyzers Market, By Type
7.5.2 Chile Clinical Chemistry Analyzers Market, By Technology
7.5.3 Chile Clinical Chemistry Analyzers Market, By End-User
7.6 Rest of Americas (ROA) Clinical Chemistry Analyzers Market
7.6.1 Rest of Americas (ROA) Clinical Chemistry Analyzers Market, By Type
7.6.2 Rest of Americas (ROA) Clinical Chemistry Analyzers Market,
7.6.3 Rest of Americas (ROA) Clinical Chemistry Analyzer Market,
8 Americas Clinical Chemistry Analyzers Market: Competitive Landscape (Page No. - 71)
8.1 Americas Clinical Chemistry Analyzers Market: Company Share Analysis
8.2 Mergers & Acquisitions
8.3 Expansion
8.4 Investments
9 Americas Clinical Chemistry Analyzers Market, By Company (Page No. - 74)
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 Hitachi High Technology Corp.
9.2 F.Hoffmann La-Roche Ltd.
9.3 Beckman Coulter Inc.
9.4 Ortho Clinical Diagnostics Inc.
9.5 Siemens Ag
9.6 Abbott Laboratories
9.7 Thermo Fisher Scientific Inc.
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 Appendix (Page No. - 89)
10.1 Customization Options
10.1.1 Product Analysis
10.1.2 Epidemiology Data
10.1.3 Surgeons’/Physicians’ Perception Analysis
10.1.4 Regulatory Framework
10.1.5 Competitive Intelligence:
10.2 Related Reports
10.3 Introducing RT: Real-Time Market Intelligence
10.3.1 RT Snapshots
List of Tables
Table 1 Global Clinical Chemistry Peer Market Size, 2014 (USD MN)
Table 2 Americas Clinical Chemistry Analyzers Market: Macroindicators,By Geography, 2014 (USD MN)
Table 3 Americas Clinical Chemistry Analyzers Market: Comparison With Parent Market, 2013–2019 (USD MN)
Table 4 Americas Clinical Chemistry Analyzers Market: Drivers and Inhibitors
Table 5 Americas Clinical Chemistry Analyzers Market, By Geography,2013-2019 (USD MN)
Table 6 Americas Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 7 Americas Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 8 Americas Clinical Chemistry Analyzers Market, By End-User,2013-2019 (USD MN)
Table 9 Americas Clinical Chemistry Analyzers Market, By Type 2013-2019 (USD MN)
Table 10 Americas Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Table 11 Americas Clinical Chemistry Analyzers Market, By Geography,2013-2019 (USD MN)
Table 12 Americas Fully Automated Clinical Chemistry Analyzers Market,2013-2019 (USD MN)
Table 13 Americas Semi-Automated Clinical Chemistry Analyzers Market,2013-2019 (USD MN)
Table 14 Americas Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 15 Americas Wet Chemistry Analyzers Market, By Country, 2013-2019 (USD MN)
Table 16 Americas Dry Chemistry Analyzers Market, By Country, 2013-2019 (USD MN)
Table 17 Americas Clinical Chemistry Analyzers Market, By Geography,2013-2019 (USD MN)
Table 18 U.S. Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 19 U.S. Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Table 20 U.S. Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 21 U.S. Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Table 22 Canada Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 23 Canada Fully Automated Clinical Chemistry Analyzers Market,By Throghput, 2013-2019 (USD MN)
Table 24 Canada Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 25 Canada Clinical Chemistry Analyzers Market, By End-User,2013-2019 (USD MN)
Table 26 Mexico Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 27 Mexico Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Table 28 Mexico Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 29 Mexico Clinical Chemistry Analyzers Market, By End-User,2013-2019 (USD MN)
Table 30 Chile Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 31 Chile Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Table 32 Chile Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Table 33 Chile Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Table 34 Rest of Americas (ROA) Clinical Chemistry Analyzers Market, By Type,2013-2019 (USD MN)
Table 35 Rest of Americas (ROA) Fully Automated Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Table 36 Rest of Americas (ROA) Clinical Chemistry Analyzers Market,By Technology, 2013-2019 (USD MN)
Table 37 Rest of Americas (ROA) Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Table 38 Americas Clinical Chemistry Analyzers Market: Company Share Analysis, 2013 (%)
Table 39 Americas Clinical Chemistry Analyzers Market: Mergers & Acquisitions
Table 40 Americas Clinical Chemistry Analyzers Market: Expansion
Table 41 Americas Clinical Chemistry Analyzers Market: Investments
Table 42 Hitachi High Technology Corp.Holdings, Inc.: Key Financials,2012-2014 (USD MN)
Table 43 F.Hoffmann La-Roche Ltd : Key Financials, 2011-2013 (USD MN)
Table 44 Beckman Coulter Inc.: Key Financials, 2011-2013 (USD MN)
Table 45 Orthoclinical Diagnostics Inc.: Key Financials, 2011-2013 (USD MN)
Table 46 Siemens Ag: Key Financials, 2011-2013 (USD MN)
Table 47 Abbott Laboratories: Key Financials, 2011-2013 (USD MN)
Table 48 Thermofisher Scientific Inc: Key Financials, 2011-2013 (USD MN)
List of Figures
Figure 1 Americas Clinical Chemistry Analyzers Market: Segmentation & Coverage
Figure 2 Clinical Chemistry Analyzers Market: Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macroindicator-Based Approach
Figure 7 Americas Clinical Chemistry Analyzers Market Snapshot
Figure 8 Americas: Clinical Chemistry Analyzers Market, By Geography,2014-2019 (USD MN)
Figure 9 Americas Clinical Chemistry Analyzers Market, By Type, 2014-2019 (USD MN)
Figure 10 Americas Clinical Chemistry Analyzers Type , By Geography, 2014 (USD MN)
Figure 11 Americas Clinical Chemistry Analyzers Market, By Technology,2014-2019 (USD MN)
Figure 12 Americas Clinical Chemistry Analyzers Market, By End-User,2014-2019 (USD MN)
Figure 13 Americas Clinical Chemistry Analyzers Market, By Type, 2014-2019 (USD MN)
Figure 14 Americas Clinical Chemistry Analyzers Market, By Geography,2013-2019 (USD MN)
Figure 15 Americas Fully Automated Clinical Chemistry Analyzers Market,2013-2019 (USD MN)
Figure 16 Americas Semi-Automated Clinical Chemistry Analyzers Market,2013-2019 (USD MN)
Figure 17 Americas Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Figure 18 Americas Wet Chemistry Analyzers Market, By Country, 2013-2019 (USD MN)
Figure 19 Americas Dry Chemistry Analyzers Market, By Country, 2013-2019 (USD MN)
Figure 20 U.S.: Clinical Chemistry Analyzers Market Share, 2014 & 2019 (%)
Figure 21 U.S.: Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Figure 22 U.S.: Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Figure 23 U.S. Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Figure 24 U.S. Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Figure 25 Canada Clinical Chemistry Analyzers Market Share, 2014 & 2019 (%)
Figure 26 Canada Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Figure 27 Canada: Fully Automated Clinical Chemistry Analyzers Market,By Throghput, 2013-2019 (USD MN)
Figure 28 Canada Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Figure 29 Canada: Clinical Chemistry Analyzers Market, By End-User,2013-2019 (USD MN)
Figure 30 Mexico Clinical Chemistry Analyzers Market Share, 2014 & 2019 (%)
Figure 31 Mexico Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Figure 32 Mexico Fully Automated Clinical Chemistry Analyzers Market,By Throghput, 2013-2019 (USD MN)
Figure 33 Mexico Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Figure 34 Mexico Clinical Chemistry Analyzers Market, By End-User,2013-2019 (USD MN)
Figure 35 Chile Clinical Chemistry Analyzers Market Overview, 2014 & 2019 (%)
Figure 36 Chile Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Figure 37 Chile Fully Automated Clinical Chemistry Analyzers Market,By Throughput, 2013-2019 (USD MN)
Figure 38 Chile Clinical Chemistry Analyzers Market, By Technology,2013-2019 (USD MN)
Figure 39 Chile Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Figure 40 Rest of Americas (ROA) Clinical Chemistry Analyzers Market Share,2014 & 2019 (%)
Figure 41 Rest of Americas (ROA) Clinical Chemistry Analyzers Market, By Type,2013-2019 (USD MN)
Figure 42 Rest of Americas (ROA) Fully Automated Clinical Chemistry Analyzers Market, By Type, 2013-2019 (USD MN)
Figure 43 Rest of Americas (ROA) Clinical Chemistry Analyzers Market,By Technology, 2013-2019 (USD MN)
Figure 44 Rest of Americas (ROA) Clinical Chemistry Analyzers Market, By End-User, 2013-2019 (USD MN)
Figure 45 Americas Clinical Chemistry Analyzers Market: Company Share Analysis, 2013 (%)
Figure 46 Hitachi High Technology Corp.Holdings Inc.: Revenue Mix, 2013 (%)
Figure 47 F.Hoffmann La-Roche Ltd. Revenue Mix, 2013 (%)
Figure 48 Beckman Coulter Revenue Mix, 2013 (%)
Figure 49 Orthoclinical Diagnostics Inc. Revenue Mix, 2013 (%)
Figure 50 Siemens Ag, Revenue Mix, 2014 (%)
Figure 51 Abbott Laboratories: Revenue Mix 2013 (%)
Figure 52 Thermofisher Scientific Inc.: Revenue Mix 2013 (%)
Clinical chemistry analyzers are the devices/instruments that read and analyse the solutions in the human body. The fluids present in the body are considered to be one of the most important parts inside the body. The main function of the fluids is to connect plethora of cells to transport essential minerals such as vitamins and calcium through arteries and veins. The content of minerals in body fluids must be accurate in order to avoid diseases such as hyponatremia.
The global clinical chemistry analyzers market, by product, was valued at $13,584.0 million in 2014 and is projected to reach $19,231.0 million by 2019, at a CAGR of 7.2% from 2014 to 2019. The leading segment, point of care under IVD, is also expected to reach $8,919.0 million by 2019 at a CAGR of 7.4%.
The Americas segment is the largest market for clinical chemistry analyzers globally, having accounted a share of 40.6% in 2013. However, the market is experiencing saturation in this region; the major influencing factor for its large market share and growth is the healthcare expenditure.
The U.S. was the largest segment in the Americas clinical chemistry analyzers market in 2013, having registered market value of $939.8 million in 2013. Aging population is one of the primary growth drivers in this region. According to the International Journal of Epidemiology, the proportion of population aged over 65 years is expected to increase from 12.7% in 2000 to 20.3% by 2050, while the proportion of population above the age of 85 is expected to increase from 1.6% in 2000 to 4.8% in 2050. The focus is, hence, more on preventative care of diseases associated with geriatrics, which include cancer, stroke, diabetes, and cardiovascular diseases (CVD). This has led to an increased demand for rapid diagnostic tests, which in turn is fostering the growth of the clinical chemistry analyzers market in the Americas. Furthermore, the major manufacturers of clinical chemistry analyzers are based in the U.S., thereby giving them easy access to this market. The presence of these major companies is also among the major factors resulting in the large share of the Americas market, globally.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Clinical Chemistry The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
European Clinical Chemistry Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Asia-Pacific Clinical Chemistry Analyzer The Asia-Pacific clinical chemistry market is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1047.2 million by 2018, at a CAGR of 16.0% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Mar 2015 |
